Law360 (April 20, 2021, 10:59 PM EDT) — The Federal Circuit on Tuesday dismissed an “unusual” appeal from drugmaker Sebela Ireland Ltd., which sought affirmation of a district court decision that claims in two patents covering its menopause drug are obvious, while at the same time asking the appellate court not to weigh in on Read more…